Advertisement
Screener

Lantheus Holdings, Inc. (LNTH) Debt / Equity

Lantheus Holdings, Inc. (LNTH) Debt / Equity

  • 2022-12-31: Debt/Equity Ratio 1.25.
  • 2021-12-31: Debt/Equity Ratio 0.38.
  • 2021-03-31: Debt/Equity Ratio 0.34.
  • 2020-12-31: Debt/Equity Ratio 0.42.

Complete source-backed debt/equity ratio history.

Available history
2015-06-30 to 2022-12-31
Data captured

Historical Debt/Equity Ratio

DateDebt/Equity Ratio
2022-12-311.25
2021-12-310.38
2021-03-310.34
2020-12-310.42
2020-09-300.43
2020-06-300.44
2020-03-311.62
2019-12-311.69
2019-09-301.94
2019-06-302.16
2019-03-313.2
2018-12-313.75
2018-09-304.81
2018-06-306
2018-03-317.95
2017-12-3111.51
2017-09-30-3.44
2017-06-30-3.08
2017-03-31-2.66
2016-12-31-2.61
2016-09-30-2.46
2016-06-30-2.12
2016-03-31-2.03
2015-12-31-1.91
2015-09-30-1.86
2015-06-30-1.81

Annual Debt/Equity Ratio

DateDebt/Equity Ratio
2022-12-311.25
2021-12-310.38
2020-12-310.42
2019-12-311.69
2018-12-313.75
2017-12-3111.51
2016-12-31-2.61
2015-12-31-1.91

Similar stocks

Stock NameCountryMarket CapPE Ratio
NEOGEN CORP (NEOG)United States$2.979B-247.49
Celldex Therapeutics, Inc. (CLDX)United States$2.471B-9.72
Intellia Therapeutics, Inc. (NTLA)United States$1.705B-5.92
ACHIEVE LIFE SCIENCES, INC. (ACHV)United States$0.806B-5.88
QuidelOrtho Corp (QDEL)United States$0.733B-0.90
Alpha Teknova, Inc. (TKNO)United States$0.500B-18.12
MYRIAD GENETICS INC (MYGN)United States$0.397B-4.84
Insight Molecular Diagnostics Inc. (IMDX)United States$0.129B-3.90
IMMUCELL CORP /DE/ (ICCC)United States$0.091B116.10
BIOMERICA INC (BMRA)United States$0.011B